Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
147,156,556
-
Share change
-
+2,856,979
-
Total reported value
-
$946,112,698
-
Put/Call ratio
-
19%
-
Price per share
-
$6.43
-
Number of holders
-
198
-
Value change
-
+$17,108,200
-
Number of buys
-
93
-
Number of sells
-
95
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q2 2015
As of 30 Jun 2015,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
198 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
147,156,556 shares.
The largest 10 holders included
FIRST TRUST ADVISORS LP, BlackRock Fund Advisors, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Gotham Asset Management, LLC, Advisors Asset Management, Inc., ACADIAN ASSET MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., Invesco Ltd., and STATE STREET CORP.
This page lists
198
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.